Fortrea Forms Strategic Collaboration with SCTbio to Advance Cell Therapy Development
Fortrea announces a strategic collaboration with SCTbio, a leader in cGMP manufacturing for cell-based therapies and viral vectors. This partnership combines Fortrea’s clinical development expertise with SCTbio’s manufacturing capabilities to deliver integrated, end-to-end solutions for cell therapy innovators—streamlining timelines, reducing risks, and accelerating the delivery of life-changing therapies worldwide.
Redefining delivery through innovation
We deliver comprehensive Phase I through IV study management, clinical pharmacology, and market access solutions to biopharma and MedTech companies around the world. We design our solutions around your needs, optimizing the development of your product and helping you advance healthcare innovation.
Breakthrough innovation starts here
We are driving a service delivery evolution with solutions that enable faster decision-making and exceptional customer experiences. Leading with science and strengthened by data, we’re shattering existing models, streamlining studies and helping sponsors bring treatments to patients faster.
With more than three decades of experience and insights, and a laser focus on customer needs, we have the breadth and depth to meet global needs, and the nimbleness to innovate at the speed of change.
Video